Cargando…
Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy
Autores principales: | Gao, Jing, Hou, Bo, Zhu, Qiwen, Yang, Lei, Jiang, Xingyu, Zou, Zhifeng, Li, Xutong, Xu, Tianfeng, Zheng, Mingyue, Chen, Yi-Hung, Xu, Zhiai, Xu, Huixiong, Yu, Haijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411121/ https://www.ncbi.nlm.nih.gov/pubmed/36008490 http://dx.doi.org/10.1038/s41467-022-32722-1 |
Ejemplares similares
-
Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy
por: Gao, Jing, et al.
Publicado: (2022) -
Author Correction: DNA-based platform for efficient and precisely targeted bioorthogonal catalysis in living systems
por: You, Yawen, et al.
Publicado: (2022) -
Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
por: Ma, Sinan, et al.
Publicado: (2022) -
Author Correction: ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
por: Chen, Yu, et al.
Publicado: (2023) -
DeepPROTACs is a deep learning-based targeted degradation predictor for PROTACs
por: Li, Fenglei, et al.
Publicado: (2022)